|

TP53-EphA-2-CAR-DC Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chinese PLA General Hospital1

Indications

  • TP53 R249S1
  • TP53 R248Q1
  • TP53 R175H1
  • TP53 R273H1
  • EphA2 Overexpression1

Other1 trial

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.